• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: PENUMBRA, INC. PENUMBRA SYSTEM RED 72 REPERFUSION CATHETER; NRY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

PENUMBRA, INC. PENUMBRA SYSTEM RED 72 REPERFUSION CATHETER; NRY Back to Search Results
Catalog Number RED72KIT
Device Problem Fracture (1260)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 10/26/2023
Event Type  malfunction  
Event Description
The patient was undergoing a thrombectomy procedure in the right internal carotid artery (ica) using a penumbra system red 72 reperfusion catheter (red72), a benchmark bmx96 access system (bmx96), a non-penumbra microcatheter, a non-penumbra stent retriever and a guidewire.It was noted that the patient¿s anatomy was tortuous.During the procedure, the physician used radial approach and completed the first pass with aspiration using the red72 and stent retriever.While removing the red72 after the first pass aspiration, the physician noticed unwinding of the red72 at the distal end.The physician removed all the catheters and switched to femoral access.The procedure was completed with two more passes using a non-penumbra sheath, a non-penumbra catheter, the same microcatheter and the same stent retriever.Thrombolysis in cerebral infarction (tici) grade 2b was achieved.There was no report of an adverse effect to the patient.
 
Manufacturer Narrative
Evaluation of the returned red72 confirmed a fracture and revealed that the catheter was ovalized near the fractured location.If the parent device becomes kinked while the red72 is inserted, damage such as a kink/ovalization may occur.This damage may contribute to resistance during retraction.Forceful retraction against this resistance likely contributed to the fracture.Further evaluation revealed kinks and ovalization along the proximal shaft, and consecutive kinks along the distal fractured segment.The distal kinks were likely due to manipulation against resistance during the procedure.The proximal damage was likely incidental to the complaint and may have occurred during packaging for return to penumbra.Penumbra catheters are inspected during in-process inspection and during quality inspection after manufacturing.The manufacturing records for this lot were reviewed and did not reveal any outstanding discrepancies, design, or quality concerns.H3 other text : placeholder.
 
Manufacturer Narrative
Please note that the following section was inadvertently missed on the initial mfr report and is being reported on this follow-up #01 mfr report:3005168196-2023-00521.1.Section h.Box 6.Results code 4 (added results code) h3 other text : placeholder.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PENUMBRA SYSTEM RED 72 REPERFUSION CATHETER
Type of Device
NRY
Manufacturer (Section D)
PENUMBRA, INC.
one penumbra place
alameda CA 94502
Manufacturer Contact
veronica farris
one penumbra place
alameda, CA 94502
5107483200
MDR Report Key18172484
MDR Text Key328890762
Report Number3005168196-2023-00521
Device Sequence Number1
Product Code NRY
UDI-Device Identifier00815948023932
UDI-Public815948023932
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K211654
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 01/01/2005,12/14/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue NumberRED72KIT
Device Lot NumberH00001805
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer10/31/2023
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? Yes
Date Report Sent to FDA01/01/2005
Date Report to Manufacturer01/10/2005
Initial Date Manufacturer Received 10/26/2023
Initial Date FDA Received11/20/2023
Supplement Dates Manufacturer Received01/14/2005
Supplement Dates FDA Received12/14/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured01/04/2023
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Age95 YR
Patient SexFemale
-
-